Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

A WWW only publication which contains articles on combinatorial chemistry accepted for publication in: Tetrahedron, Tetrahedron Letters, Tetrahedron:Asymmetry, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, CarbohydrateResearch, and other relevant Elsevier Science journals. It also features specially commissioned topical reports, as well as abstracts of articles from other publications. Articles are designated with page number and are published continuously in annual volumes.

chemie --- Descriptive organic chemistry --- Combinatorial chemistry --- Chimie combinatoire --- Periodicals. --- Périodiques --- Combinatorial chemistry. --- Biotechnologie. --- Zeitschrift. --- Online-Publikation. --- Kombinatorische Synthese. --- Combinatorial organic synthesis --- Combinatorial synthesis (Organic chemistry) --- High-throughput organic synthesis --- High-throughput synthesis (Organic chemistry) --- Multiple parallel synthesis (Organic chemistry) --- Biotechnologie --- Kombinatorische Synthese --- Online-Ressource --- Zeitschrift --- Organic compounds --- Pharmaceutical chemistry --- Biochips --- Periodikum --- Zeitschriften --- Presse --- Fortlaufendes Sammelwerk --- Netzpublikation --- Online-Publikation --- Computerdatei im Fernzugriff --- Online-Dokument --- On-line-Dokument --- On-line-Publikation --- Elektronische Publikation --- Kombinatorische Chemie --- Kombinatorische Biologie --- Biokombinatorische Synthese --- Organische Synthese --- Molekülbibliothek --- Technische Biochemie --- Technische Biologie --- Biotechnik --- Biotech --- Industrielle Mikrobiologie --- Synthesis --- Molekülbibliothek --- Online-Ressource.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Technology --- Biomedical Engineering --- Bioengineering --- Biotechnology --- Biomedical Engineering. --- Technology. --- Biotechnologie --- Bioengineering. --- Biotechnology. --- Zeitschrift --- Online-Ressource --- Molekularbiologie --- Périodiques. --- Biological engineering --- Life science engineering --- Arts, Industrial --- Industrial Arts --- Engineering, Biomedical --- Clinical Engineering --- Engineering, Clinical --- Molekulare Biologie --- Netzpublikation --- Online-Publikation --- Computerdatei im Fernzugriff --- Online-Dokument --- On-line-Dokument --- On-line-Publikation --- Periodikum --- Zeitschriften --- Technische Biochemie --- Technische Biologie --- Biotechnik --- Biotech --- Cloud Computing --- Biomedical Technology --- Chemical engineering --- Genetic engineering --- Biology --- Engineering --- Synthetic biology --- Biologie --- Biochemie --- Elektronische Publikation --- Presse --- Fortlaufendes Sammelwerk --- Industrielle Mikrobiologie --- Biotechnologie. --- Biological sciences. --- Science and technology. --- biochemie --- biochemistry --- biotechnologie --- biotechnology --- chemische industrie --- chemical industry --- fermentatie --- fermentation --- voedselbiotechnologie --- food biotechnology --- Biotechnology (General) --- Food and Bioprocess Engineering (General) --- Biotechnologie (algemeen) --- Levensmiddelen- en bioproceskunde (algemeen) --- Biomedical engineering. --- Génie biomédical. --- Technologie. --- biomedical engineering. --- Clinical engineering --- Medical engineering --- Biophysics --- Medicine --- Applied science --- Arts, Useful --- Science, Applied --- Useful arts --- Science --- Industrial arts --- Material culture --- Zeitschrift. --- Online-Ressource. --- Molekularbiologie.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The

Pharmaceutical industry. --- Prescription pricing. --- Prescription pricing --- Drugs --- Pharmaceutical industry --- Consumer education --- Public Sector --- Private Sector --- Biomedical Research --- Drug Therapy --- Drug Costs --- Drug Industry --- Research Support as Topic --- Financing, Government --- Health Care Costs --- Therapeutics --- Research --- Industry --- Ownership --- Financing, Organized --- Financial Support --- Social Sciences --- Organization and Administration --- Anthropology, Education, Sociology and Social Phenomena --- Delivery of Health Care --- Costs and Cost Analysis --- Economics --- Technology, Industry, and Agriculture --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Science --- Health Services Administration --- Health Care Quality, Access, and Evaluation --- Health Care Economics and Organizations --- Natural Science Disciplines --- Technology, Industry, Agriculture --- Health Care --- Disciplines and Occupations --- Pharmacy, Therapeutics, & Pharmacology --- Health & Biological Sciences --- Prices --- Consumer education. --- Prices. --- Buyers' guides --- Shoppers' guides --- Drug industry --- Drug trade --- Consumer affairs departments --- Consumers' leagues --- Education --- Home economics --- Shopping --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Pricing --- american society. --- biochemists. --- biotech drugs. --- drug companies. --- drug cost. --- drug culture. --- drug funding. --- drug innovation. --- drug manufacturing. --- drug pricing. --- expose piece. --- genetic disorders. --- government funded research. --- high costs. --- human genome project. --- investments. --- medical breakthroughs. --- medical innovations. --- medical research. --- pharmaceutical companies. --- prescription drugs. --- private sector. --- public heath. --- public sector. --- research and development. --- us government.